Marseille 2007
| Abstract #78 - Sustainability and scaling up HAART in Benin: An economic analysis | ||||
|
Session: 11.4: Cost (Parallel) on Monday @ 11.00-12.30 in HC Chaired by Eileen Stillwaggon, Didier Fassin Authors: Presenting Author: Dr Sennen HOUNTON - Centre MURAZ, Burkina Faso |
||||
| Additional Authors: | ||||
| Aim: The study aimed to cost care and support for people living with HIV/AIDS (PLWHA) and estimate their willingness to pay (WTP) in order to assist decision making regarding the sustainability and scaling up of access to HAART in Benin | ||||
| Method / Issue: A prospective study was used to collect data on costs of the Ambulatory Treatment Center (ATC) of the National teaching hospital in Cotonou, Benin and costs borne by 122 PLWHA and families to access care. We used a micro costing approach and WHO guidelines for costing health services for resources useful life years. Annual costs were subsequently derived from both PLWHA and societal perspectives. WTP were estimated using contingent valuation with open ended questions. The analysis time horizon was 10 years and sensitivity analysis were conducted on major costs categories. | ||||
| Results / Comments: The study population was mostly of middle age (median age of 38, IQR 34-42), married (65%), working class (60%) with low literacy (70% primary level or less). Annualised ATC costs and costs borne by PLWHA respectively amounted to 1,200,000 USD and 1680 USD. The main drivers of costs were drugs (74%) and biological monitoring (14%). PLWHA were willing to pay 24USD per year for services received and incurred catastrophic health expenditures. Using the estimated expected number of PLWHA and Ambulatory Treatment Centers an approximate 12,000 000 USD will be necessary to ensure continuity of drugs supply and biological monitoring for PLWHA for the next ten years | ||||
| Discussion: Drugs and biological monitoring remain the main barriers to quality care for PLWHA and any cost recovery strategy is unlikely to face a monthly shortage of drugs and laboratory. Results may assist in decision making regarding resources allocation at national and international levels to ensure sustainable and universal care for PLWHA. | ||||
| Go Back | ||||
